China vs Switzerland: 10_Insured export credit exposures, short term
China
61.49 billion BU
in 2025
Switzerland
56.32 billion BU
in 2025
China rank
8th
Switzerland rank
9th
10_Insured export credit exposures, short term over time
- China
- Switzerland
How they compare
China currently reports 61.49 billion BU against 56.32 billion BU in Switzerland, a difference of 5.17 billion BU.
That makes China's figure about 1.1 times Switzerland's.
Across all 21 years both countries report, China has been ahead every year.
China ranks 8th and Switzerland ranks 9th of 210 countries.
China has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | China | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 25.84 billion BU | 16.85 billion BU | 8.99 billion BU | China |
| 2010s | 43.63 billion BU | 30.25 billion BU | 13.39 billion BU | China |
| 2020s | 63.43 billion BU | 51.87 billion BU | 11.56 billion BU | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher 10_insured export credit exposures, short term, China or Switzerland?
- China, at 61.49 billion BU against 56.32 billion BU in Switzerland as of 2025.
- What is the difference in 10_insured export credit exposures, short term between China and Switzerland?
- 5.17 billion BU, with China ahead.
- How many years of comparable data are there for China and Switzerland?
- 21 years are reported by both, from 2005 to 2025.
- How do China and Switzerland rank globally for 10_insured export credit exposures, short term?
- China ranks 8th and Switzerland ranks 9th of 210 countries.
- Where does this data come from?
- BIS, published as 10_Insured export credit exposures, short term (BU). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
ST refers to insured export credits with credit terms up to and including 12 months, except for transactions involving an insured manufacturing (pre-credit) risk with a risk period of more than 12 months, which are classified as medium/long-term (MLT).